TruBridge, Inc. (NASDAQ:TBRG – Get Free Report) major shareholder Pinetree Capital Ltd. bought 3,997 shares of the company’s stock in a transaction dated Wednesday, October 2nd. The stock was bought at an average price of $11.93 per share, for a total transaction of $47,684.21. Following the acquisition, the insider now directly owns 603,997 shares of the company’s stock, valued at approximately $7,205,684.21. This represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Large shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.
TruBridge Stock Performance
TBRG stock traded up $0.02 during midday trading on Friday, hitting $11.88. The company’s stock had a trading volume of 62,351 shares, compared to its average volume of 163,111. The stock has a market cap of $178.28 million, a price-to-earnings ratio of -3.40, a PEG ratio of 2.80 and a beta of 0.62. The company has a quick ratio of 1.76, a current ratio of 1.77 and a debt-to-equity ratio of 0.98. The stock’s 50-day moving average price is $11.97 and its 200 day moving average price is $10.37. TruBridge, Inc. has a 1 year low of $7.55 and a 1 year high of $17.21.
TruBridge (NASDAQ:TBRG – Get Free Report) last posted its quarterly earnings results on Thursday, August 8th. The company reported $0.08 earnings per share for the quarter, missing the consensus estimate of $0.15 by ($0.07). TruBridge had a negative net margin of 15.93% and a positive return on equity of 6.57%. The company had revenue of $84.73 million for the quarter, compared to the consensus estimate of $80.71 million. On average, equities analysts forecast that TruBridge, Inc. will post 0.56 EPS for the current year.
Institutional Investors Weigh In On TruBridge
Analyst Upgrades and Downgrades
Several research firms have recently issued reports on TBRG. Cantor Fitzgerald reiterated an “overweight” rating and issued a $13.00 target price on shares of TruBridge in a research note on Friday. Royal Bank of Canada reiterated an “outperform” rating and issued a $14.00 price objective on shares of TruBridge in a research note on Tuesday, September 17th.
Get Our Latest Research Report on TruBridge
TruBridge Company Profile
TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.
Read More
- Five stocks we like better than TruBridge
- What is the Dogs of the Dow Strategy? Overview and Examples
- The Outlook for Interest Rate Cuts Got Blown Out of the Water
- Airline Stocks – Top Airline Stocks to Buy Now
- 3 High-Risk, High-Reward Micro-Cap Stocks You Shouldn’t Ignore
- Compound Interest and Why It Matters When Investing
- 3 Bargain Stocks Positioned for Gains After Missing 2024’s Rally
Receive News & Ratings for TruBridge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TruBridge and related companies with MarketBeat.com's FREE daily email newsletter.